GO
Loading...

Enter multiple symbols separated by commas

Search results for "JNJ"

REFINE RESULTS

SEARCH RESULTS

About 61 results. Sort By: Date | Relevance
UPDATE 1-FBI probing what J&J knew about uterine surgery device - WSJ

May 27- The Federal Bureau of Investigation is probing a surgical tool found to spread uterine cancer and what Johnson& Johnson knew about its risks before withdrawing its version of the device last year, the Wall Street Journal reported. A J&J spokesman said the company has not been contacted by the FBI regarding its Ethicon morcellation devices.
Source: Reuters
FBI probing what J&J knew about uterine surgery device - WSJ

May 27- The Federal Bureau of Investigation is looking into what Johnson& Johnson knew about the risks posed by a surgical tool in spreading uterine cancer before withdrawing its version of the device last year, the Wall Street Journal reported. J&J said in July that it would ask doctors to return the device, called laparoscopic power morcellator, which is used to...
Source: Reuters
US not thinking about extending nuclear talks  

The U.S. is not thinking about extending nuclear talks; the FAA says it has created a working group to study the mental health of pilots; and the annual national spelling bee has begun, reports CNBC's Sue Herera.
Source: CNBC.com
Utah defends contentious law on contact lens price-fixing

SALT LAKE CITY- Utah state attorneys have asked an appeals court to clear the way for a contentious law that bans price fixing by contact lens makers and could have wide-ranging implications for the $4 billion industry. They were joined by the discount retailers Costco and Utah- based 1-800 Contacts. Suing to block the law are lens makers Alcon Laboratories,...
Source: The Associated Press
Stocks close 1% lower as Dow plunges triple digits; dollar, data weigh

U.S. stocks closed about 1 percent lower as investors eyed renewed strength in the dollar and data that could strengthen the case for a rate hike.
Source: CNBC.com | By: Evelyn Cheng
Abbvie completes $21 billion buyout of Pharmacyclics

NEW YORK- Abbvie has completed its $21 billion buyout of Pharmacyclics. The buyout adds another major revenue producer to Abbvie's portfolio, which already includes the world's top-selling drug, Humira. Pharmacyclics Inc. will become a subsidiary of Abbvie and operate from its Sunnyvale, California headquarters.
Source: The Associated Press
INTERVIEW-Bavarian Nordic not for sale after big pharma deals

COPENHAGEN, May 26- Bavarian Nordic is hot property after striking two big vaccine deals but the small Danish company is not for sale, despite a wave of consolidation in the healthcare industry, its chief told Reuters. Boosting the immune system is now a top priority for cancer drug companies such as Bristol-Myers, Merck, Roche and AstraZeneca, fuelling renewed...
Source: Reuters | By: Sabina Zawadzki
California Assembly advances ban on microbeads in cosmetics

SACRAMENTO, Calif.- The California Assembly on Friday approved one of the nation's toughest bans on plastic, exfoliating microbeads that are polluting waterways. Manufacturers already have pledged to phase out the materials, including L'Oreal, Unilever and Johnson& Johnson, and use natural alternatives such as apricot shells and cocoa beans.
Source: The Associated Press | By: By FENIT NIRAPPIL, Associated Press
Condom company in sticky situation over lube deal

Reckitt Benckiser's planned purchase of a leading personal lubricant brand has come under scrutiny by a competition authority.
Source: CNBC.com | By: Katrina Bishop
Stocks across all generations  

According to TD Ameritrade Apple is the most widely held stock among all generations.
Source: CNBC.com